SOTYKTU (deucravacitinib) is a prescription medicine used to treat adults with moderate-to-severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy). It is not known if SOTYKTU is safe and effective in children under 18 years of age.
RESOURCES AND SUPPORT
WE'RE HERE TO HELP ALONG THE WAY
If you’ve started on SOTYKTU and are interested in support materials that may help you along your treatment path, or if you’re considering SOTYKTU and want to know what’s available to you, we’re here for you. Below are downloadable resources and information to help you along your treatment path.
I'M CONSIDERING TREATMENT
Get to Know SOTYKTU Brochure
Call it SOTYKTU 101—an introduction to SOTYKTU, featuring trial results, safety information, support offerings, and more.
Everyone who’s been prescribed SOTYKTU is invited to enroll in our program with a support team to help guide you, insurance resources to inform you, savings programs that may help you, and continued communications to encourage you.